Sort
78,016 grants matching “breast cancer”
Optimizing Endocrine Therapy Adherence through Motivational Interviewing and Text Interventions
$621,496Stephanie Brooke Wheeler · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
A Randomized Trial of Physical Activity for Cognitive Functioning in Breast Cancer Survivors
$621,430Sheri J Hartman · University Of California, San Diego · R01 · FY2019 · CA
COPY NUMBER VARIANTS AND EARLY-ONSET BREAST CANCER
$621,400Paul Joseph Goodfellow · Washington University · R01 · FY2011 · CA
Behavioral Influences on Ovarian Cancer Progression: Role of Chemoresistance
$621,318Susan K Lutgendorf · University Of Iowa · R01 · FY2017 · CA
Epidemiologic factors and survival by molecular subtypes of ovarian cancer
$621,252Mary Anne Rossing · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA
Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung Cancer
$621,239Ming You · Medical College Of Wisconsin · R01 · FY2019 · CA
Novel Biomarkers for Aromatase Inhibitor Therapy
$621,180Washington University · R01 · FY2003 · CA
DNA Repair Phenotype the Missing Link in Breast Cancer Risk Assessment
$621,179Mary Beth Terry · Columbia University Health Sciences · U01 · FY2021 · ES
Abbreviated Non-Contrast-Enhanced MRI for Breast Cancer Screening
$621,162Brian Andrew Hargreaves · Stanford University · R01 · FY2021 · CA
Imaging Modulation of Immune Phenotype
$621,116Katherine W Ferrara · Stanford University · R01 · FY2024 · CA
Reproductive Hormones - Biological and Molecular Actions
$621,103Bert W O'Malley · Baylor College Of Medicine · R01 · FY2018 · HD
Reproductive Hormones - Biological and Molecular Actions
$621,103Bert W O'Malley · Baylor College Of Medicine · R01 · FY2014 · HD
Reproductive Hormones - Biological and Molecular Actions
$621,103Bert W O'Malley · Baylor College Of Medicine · R01 · FY2017 · HD
Automated Density Measures for Estimating Breast Cancer Risk and Therapy Response
$621,043Celine M Vachon · Mayo Clinic Rochester · R01 · FY2013 · CA
Development of TGF-beta antagonists for cancer therapy
$621,015Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
High-resolution lower dose dedicated breast CT
$620,998Srinivasan Vedantham · Univ Of Massachusetts Med Sch Worcester · R01 · FY2016 · CA
Biochemistry of Pre-mRNA Splicing
$620,984Adrian R Krainer · Cold Spring Harbor Laboratory · R01 · FY2007 · GM
Resorbable Inferior Vena Cava Filter
$620,973Mitchell Eggers · Adient Medical, Inc. · R44 · FY2016 · HL
Synergized Immune and Tumor Cell Bone Marrow Biomarkers to Predict Recurrence in Triple Negative Breast Cancer
$620,943Rebecca L Aft · Washington University · R01 · FY2024 · CA
Environmental chemicals impair epigenetic suppression of the endogenous retrovirus HML-2 in human primordial germ cells, predisposing the next generation to malignancies through HML-2 reactivation
$620,940Toshihiro Shioda · Massachusetts General Hospital · R01 · FY2024 · ES
Toward translation of a plant virus-based in situ vaccination nanotechnology
$620,922Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2025 · CA
Radiomic phenotypes of breast parenchyma and association with breast cancer risk and detection
$620,863Celine M Vachon · Mayo Clinic Rochester · R01 · FY2019 · CA
Tyrosine phosphorylation of p27Kip1 as a biomarker to identify Cdk4/6 inhibitor response
$620,808Janice L Brissette · Suny Downstate Medical Center · R01 · FY2022 · CA
NCI Community Oncology Research Program (NCORP) Community Sites
$620,783Albert Denittis · Lankenau Institute For Medical Research · UG1 · FY2016 · CA
Bladder cancer PD-L1 control of homologous recombination: Basic mechanisms applied to novel treatments
$620,740Tyler J. Curiel · Dartmouth-Hitchcock Clinic · R01 · FY2023 · CA